DiscoverExpert Voices in DementiaKey Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More
Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Update: 2025-10-09
Share

Description

Ana C. Pereira, MD, Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY, discusses key takeaways about the impact of patient lifestyle modifications on brain health, updates in biomarkers and disease-modifying therapies, and new frontiers in Alzheimer disease research based on research presented at the 2025 meeting of the Alzheimer’s Association International Conference (AAIC).

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
In Channel
Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

2025-10-0911:10

The Brain Health Navigator: A Novel Program to Improve Alzheimer Disease Care

The Brain Health Navigator: A Novel Program to Improve Alzheimer Disease Care

2025-10-0814:52

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

2025-09-0921:26

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

2025-05-0117:42

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

2025-03-2120:59

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

2025-02-2511:31

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

2025-01-2516:27

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

2024-12-1910:42

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

2024-11-1915:41

BrainCheck as a Digital Cognitive Assessment Tool

BrainCheck as a Digital Cognitive Assessment Tool

2024-11-0807:17

Kramer, Van Dyck

Kramer, Van Dyck

2024-09-2712:18

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

2024-09-2110:14

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

2024-09-2117:02

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

2024-09-2108:53

Labcorp's Biomarker Testing for Alzheimer Disease

Labcorp's Biomarker Testing for Alzheimer Disease

2024-09-1612:50

What Neurologists Should Know About End-of-Life Care Discussions

What Neurologists Should Know About End-of-Life Care Discussions

2024-07-1920:47

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

2024-07-1522:07

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

2024-07-1509:22

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

2024-07-1508:51

Emerging Therapeutic Targets for Alzheimer Disease

Emerging Therapeutic Targets for Alzheimer Disease

2024-07-1514:27

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Practical Neurology